Liquidia Corporation (LT4.SG)
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States.
74.44-0.01%
StockGlow Score
Bullish
BearishBullish
1 year ago+360.4%
The outlook
Liquidia Corporation currently reads as bullish based on above its 50- & 200-day averages, 92% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range92% of the way from its 52-week low to high
Market cap
$6.37B
52-wk high
79.50
52-wk low
16.17
50-day avg
63.49
200-day avg
40.66
Trailing P/E
—